First Time Loading...

Zoono Group Ltd
ASX:ZNO

Watchlist Manager
Zoono Group Ltd Logo
Zoono Group Ltd
ASX:ZNO
Watchlist
Price: 0.055 AUD -9.84% Market Closed
Updated: Apr 26, 2024

Intrinsic Value

ZNO doesn't have a meaningful market cap.

Zoono Group Ltd. is a pharmaceutical and biotechnology company. [ Read More ]

The intrinsic value of one ZNO stock under the Base Case scenario is 0.026 AUD. Compared to the current market price of 0.055 AUD, Zoono Group Ltd is Overvalued by 54%.

Key Points:
ZNO Intrinsic Value
Base Case
0.026 AUD
Overvaluation 54%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Zoono Group Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ZNO stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Zoono Group Ltd

Provide an overview of the primary business activities
of Zoono Group Ltd.

What unique competitive advantages
does Zoono Group Ltd hold over its rivals?

What risks and challenges
does Zoono Group Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Zoono Group Ltd.

Provide P/S
for Zoono Group Ltd.

Provide P/E
for Zoono Group Ltd.

Provide P/OCF
for Zoono Group Ltd.

Provide P/FCFE
for Zoono Group Ltd.

Provide P/B
for Zoono Group Ltd.

Provide EV/S
for Zoono Group Ltd.

Provide EV/GP
for Zoono Group Ltd.

Provide EV/EBITDA
for Zoono Group Ltd.

Provide EV/EBIT
for Zoono Group Ltd.

Provide EV/OCF
for Zoono Group Ltd.

Provide EV/FCFF
for Zoono Group Ltd.

Provide EV/IC
for Zoono Group Ltd.

Compare the intrinsic valuations
of Zoono Group Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Zoono Group Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Zoono Group Ltd compared to its peers.

Compare the P/E ratios
of Zoono Group Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Zoono Group Ltd with its peers.

Analyze the financial leverage
of Zoono Group Ltd compared to its main competitors.

Show all profitability ratios
for Zoono Group Ltd.

Provide ROE
for Zoono Group Ltd.

Provide ROA
for Zoono Group Ltd.

Provide ROIC
for Zoono Group Ltd.

Provide ROCE
for Zoono Group Ltd.

Provide Gross Margin
for Zoono Group Ltd.

Provide Operating Margin
for Zoono Group Ltd.

Provide Net Margin
for Zoono Group Ltd.

Provide FCF Margin
for Zoono Group Ltd.

Show all solvency ratios
for Zoono Group Ltd.

Provide D/E Ratio
for Zoono Group Ltd.

Provide D/A Ratio
for Zoono Group Ltd.

Provide Interest Coverage Ratio
for Zoono Group Ltd.

Provide Altman Z-Score Ratio
for Zoono Group Ltd.

Provide Quick Ratio
for Zoono Group Ltd.

Provide Current Ratio
for Zoono Group Ltd.

Provide Cash Ratio
for Zoono Group Ltd.

What is the historical Revenue growth
over the last 5 years for Zoono Group Ltd?

What is the historical Net Income growth
over the last 5 years for Zoono Group Ltd?

What is the current Free Cash Flow
of Zoono Group Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Zoono Group Ltd.

Financials

Balance Sheet Decomposition
Zoono Group Ltd

Current Assets 7.9m
Cash & Short-Term Investments 136.3k
Receivables 230.7k
Other Current Assets 7.6m
Non-Current Assets 1.3m
PP&E 1.3m
Intangibles 1.6k
Current Liabilities 1.7m
Accounts Payable 706.8k
Accrued Liabilities 45.7k
Other Current Liabilities 963.6k
Non-Current Liabilities 2.1m
Long-Term Debt 711.9k
Other Non-Current Liabilities 1.3m
Efficiency

Earnings Waterfall
Zoono Group Ltd

Revenue
2.1m NZD
Cost of Revenue
-1.2m NZD
Gross Profit
935.3k NZD
Operating Expenses
-8.5m NZD
Operating Income
-7.5m NZD
Other Expenses
-125.7k NZD
Net Income
-7.7m NZD

Free Cash Flow Analysis
Zoono Group Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

ZNO Profitability Score
Profitability Due Diligence

Zoono Group Ltd's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROIC
Negative 1-Year Revenue Growth
Declining ROE
23/100
Profitability
Score

Zoono Group Ltd's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

ZNO Solvency Score
Solvency Due Diligence

Zoono Group Ltd's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Short-Term Solvency
Low D/E
Long-Term Solvency
64/100
Solvency
Score

Zoono Group Ltd's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ZNO Price Targets Summary
Zoono Group Ltd

There are no price targets for ZNO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

ZNO Price
Zoono Group Ltd

1M 1M
-52%
6M 6M
+20%
1Y 1Y
+5%
3Y 3Y
-94%
5Y 5Y
-35%
10Y 10Y
-94%
Annual Price Range
0.055
52w Low
0.034
52w High
0.125
Price Metrics
Average Annual Return 161.21%
Standard Deviation of Annual Returns 365.39%
Max Drawdown -99%
Shares Statistics
Market Capitalization 17.3m AUD
Shares Outstanding 314 708 000
Percentage of Shares Shorted
N/A

ZNO Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Zoono Group Ltd Logo
Zoono Group Ltd

Country

Australia

Industry

Chemicals

Market Cap

17.3m AUD

Dividend Yield

0%

Description

Zoono Group Ltd. is a pharmaceutical and biotechnology company. The company is headquartered in Sydney, New South Wales. The firm is focused on developing, manufacturing and distributing of scientifically validated antimicrobial solutions. The firm's products are based on the Zoono molecule, which is an antimicrobial molecule that bonds to any surface and kills pathogens including bacteria, viruses, algae, fungi and mould. The firm's products include sprays, wipes and foams suited for skin care, surface sanitizers, and mould remediation treatments. Its sanitizer products include surface sanitizer and hand sanitizer.

Contact

NEW SOUTH WALES
Sydney
L 12 225 George St
+61280428481.0
http://www.goldsearch.com/

IPO

1988-07-21

Employees

-

Officers

Chief Financial Officer
Mr. Paul Ravlich CA, MBA
Chief Operating Officer
Mr. Lewis Andrew Craig MacKinnon
MD & Director
Mr. Paul Hyslop
Company Secretary & Independent Non-Executive Director
Ms. Elissa C. Hansen ACSA, B.Com., B.Comm, FCIS, Gad Dip ACG, GAI, GAIC

See Also

Discover More
What is the Intrinsic Value of one ZNO stock?

The intrinsic value of one ZNO stock under the Base Case scenario is 0.026 AUD.

Is ZNO stock undervalued or overvalued?

Compared to the current market price of 0.055 AUD, Zoono Group Ltd is Overvalued by 54%.